Advertisement

Pharmacy World and Science

, Volume 19, Issue 5, pp 236–245 | Cite as

Discussion of the AED workshop.

  • Santiago Grau
  • Josep Monterde
  • Ludvik Drobnic
  • Margarita Salvadó
Article

Abstract

Urinary tract infections (UTI) include a wide range of clinical entities. Starting from this situation, have been differentiated each of the UTI depending on location, age and sex, among other factors. Therefore, UTI have been classified and studied as follows: UTI in women, in men, in elderly people, in catheterized patients and in children. The different pharmacotherapeutic alternatives have been assessed and the classic agents compared with the most recent molecules.

Pharmacotherapeutic alternatives Review Urinary tract infections 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stamm WE. Nosocomial urinary tract infections. In: Bennett JV, Brachman PS, eds. Hospital Infections. Boston: Little, Brown and Company, 1992: 597–610.Google Scholar
  2. 2.
    Vaqué J, ed. Prevalencia de las infecciones nosocomiales en los hospitales españoles: EPINE 1990-1994. Barcelona: Sociedad Española de Higiene y Medicina Preventiva Hospitalarias, 1995.Google Scholar
  3. 3.
    Hatton J, Hughes M, Raymond CH. Management of bacterial urinary tract infections in adults. Ann Pharmacother 1994;28: 1264–72.Google Scholar
  4. 4.
    Hooton TM, Stamm WE. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am 1991;75: 339–57.Google Scholar
  5. 5.
    Ward TT, Jones SR. Infecciones del tracto genitourinario. In: Reese RE, Betts RF, eds. Un planteamiento practico de las enfermedades infecciosas. Jarpyo editores, Madrid, 1191: 393–427.Google Scholar
  6. 6.
    Nicolle LE, Herding GKM, Preiksaitis J. The association of urinary tract infection with sexual intercourse. J Infect Dis 1982; 146: 579–82.Google Scholar
  7. 7.
    Storm BL, Collins M, West SL. Sexual activity, contraceptive use, and other risk factors for symptomatic and asyptomatic bacteriuria. A case control study. Ann Intern Med 1987;107: 816–20.Google Scholar
  8. 8.
    Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329: 753–6.Google Scholar
  9. 9.
    Nicolle LE, Bjornson J, Harding GKM et al. Bacteriuria in elderly institutionalized men. N Engl J Med 1983;309:1420–5.Google Scholar
  10. 10.
    Yoshikawa TT. Chronic urinary tract infections in elderly patients. Hosp Prac 1993;28: 103–18.Google Scholar
  11. 11.
    Nicolle LE. Urinary tract infection in the elderly: how to treat and when? Infection 1992;20(suppl 4): S261–S265.Google Scholar
  12. 12.
    Nicolle LE. Urinary tract infection in the elderly. J Antimicrob Chemother 1994;33(suppl A): 99–109.Google Scholar
  13. 13.
    Haley RW, Gaynes RP, Aber RC, Bennett JV. Surveillance of nosocomial infections. In: Bennett JV, Brachman PS, editors. Hospital Infections. Boston: Little, Brown and Company, 1992: 79–108.Google Scholar
  14. 14.
    Johnson JR, Stamm WE. Urinary tract infections in women: diagnosis and treatment. Ann Intern Med 1989;111: 906–17.Google Scholar
  15. 15.
    Neu HC. Optimal characteristics of agents to treat uncomplicated urinary tract infections. Infections 1992;20(suppl 4) S266–S271.Google Scholar
  16. 16.
    Svanborg-Eden C, Eriksson B, Hanson LA. Adhesion of Escherichia coli to human uroepitelial cells in vitro. Infect Immun 1977;18: 767–74.Google Scholar
  17. 17.
    Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329: 1328–34.Google Scholar
  18. 18.
    Del Rio G, Dalet F. Ciprofloxacino en las infecciones urinarias en la practica ambulatoria. In: Foz A, Roy C, eds. Medicine. Patologia infecciosa básica. Madrid: IDEPSA, 1989: 329–34.Google Scholar
  19. 19.
    Turnidge J. Principles of appropiate prescribing of antimicrobials. Australian Journal of Hospital Pharmacy. 1995;25: 202–6.Google Scholar
  20. 20.
    Kass EH. 1956. Asymptomatic infections of the urinary tract. Trans. Assoc. Phys. 69: 56–64.Google Scholar
  21. 21.
    Kass EH. 1957. Bacteriuria and the diagnosis of infections of the urinary tract. Arch. Inter. Med. 100: 709–14.Google Scholar
  22. 22.
    Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982;307: 463–8.Google Scholar
  23. 23.
    Del Rio G. Tratamiento de las infecciones urinarias. In: Drobnic L, ed. Tratamiento antimicrobiano. Barcelona: Doyma, 1993: 359–66.Google Scholar
  24. 24.
    Gómez J, Pérez M, Hernández JL, Herrero F, Brotons ML, Baños V et al. Bases del uso de antibióticos en las infecciones urinarias. Farmacoterapia 1993;10: 78–86.Google Scholar
  25. 25.
    Pfau A, Sacks TG. Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women. J Urol 1994;152: 136–8.Google Scholar
  26. 26.
    Saginur R, Nicolle LE. Single-dose compared with 3-day norfloxacine treatment of uncomplicated urinary tract infection in women. Arch Intern Med, 1992;152: 1233–7. 27.Google Scholar
  27. 27.
    Arnal J. Infección urinaria. In: Romero R, Caralps A, eds. Barcelona: Doyma, 1985: 1–38.Google Scholar
  28. 28.
    Del Rio G, Dalet F. Infecciones urinarias II. Tratamiento y profilaxis. Bol Inf Com 1991;1: 72–9.Google Scholar
  29. 29.
    Rodriguez JC, Ruiz M, Elía M, Royo G. Sensibilidad de los patógenos aislados de infecciones urinarias. Rev Esp Quimioterap 1995;8: 73–4.Google Scholar
  30. 30.
    Ronald AR. Urethritis and cystitis. In: Hoeprich PD, Jordan MC, Ronald AR, eds. Infectious diseases. Philadelphia: JB Lippincott Company, 1994: 564–70.Google Scholar
  31. 31.
    Thomson KS, Sanders E, Sanders CC. USA resistance patterns among UTI pathogens. J Antimicrob Chemother 1994; 33(suppl A): 9–15.Google Scholar
  32. 32.
    Grüneberg RN. Changes in urinary pathogens and their anti-biotic sensitivities. J. Antimicrob Chemother 1994;33 (suppl A): 1–8.Google Scholar
  33. 33.
    Mensa J, Gatell JM, Jiménez de Anta MT, Prats G, Corachán M, Escofet MC, et al. eds. Guía de Terapéutica Antimicrobiana. Barcelona: Massson S.A. 1996.Google Scholar
  34. 34.
    Drobnic L, Grau S, Salas E, Del Villar A, Monterde J, Martínez-Roig A, eds. Guía de Terapéutica Antimicrobiana del Hospital del Mar. Barcelona: IMAS. Hospital del Mar, 1995.Google Scholar
  35. 35.
    Cherney CL, Kaye D. Bacteriuria and pyelonephritis. In: Kass EH, Platt R, eds. Current therapy in infectious disease. Philadelphia: BC Decker Inc, 1990: 190–4.Google Scholar
  36. 36.
    Sanford JP, Gilbert DN, Sande MA, eds. Guide to Antimicrobial Therapy. Dallas: Antimicrobial Therapy Inc., 1996.Google Scholar
  37. 37.
    Sobel JD, Kaye D. Urinary tract infections. In: Mandel GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone Inc, 1995: 662–90.Google Scholar
  38. 38.
    Bailey RR. Cost-benefit consideration in the management of uncomplicated urinary tract infections in sexually active women. N Z Med J 1987;100: 680–3.Google Scholar
  39. 39.
    Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis 1990;12: 458–67.Google Scholar
  40. 40.
    Kunin CM. Urinary Tract Infections in Females. Clin Infect Dis 1994;18: 1–12.Google Scholar
  41. 41.
    Masterton RG, Bochsler JA. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J Antimicrob Chemother 1995;35: 129–37.Google Scholar
  42. 42.
    Ronald AR, Nicolle LE, Harding GKM. Standards of therapy for urinary tract infections in adults. Infection 1992;20(Suppl 3): S164–S170.Google Scholar
  43. 43.
    Rubin RH, Shapiro ED, Andriole VT, et al. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis 1992;15(Suppl 1): S216–S227.Google Scholar
  44. 44.
    Phisicians' Desk Reference. Medical Economics. 1995: 2356.Google Scholar
  45. 45.
    The Medical Letter: Choice of Cephalosporins. New Rochelle: The Medical Letter Inc 1990;32: 107–10.Google Scholar
  46. 46.
    Neu HC. Fosfomycin-Trometamol: Management of Lower Urinary Tract Infections. Chemother. 1990;36(suppl 1): 53–5.Google Scholar
  47. 47.
    Gómez J, Hernández JL. Fosfomicina y polimixinas. In: Drobnic L, ed. Tratamiento antimicrobiano. Barcelona: Doyma SA, 1993: 201–9.Google Scholar
  48. 48.
    Leibovici L, Greenshtain S, Cohen O et al. Toward improved empiric management of moderate to severe urinary tract infections. Arch Intern Med 1992;152: 2481–6.Google Scholar
  49. 49.
    Shea DJ. Pyelonephritis and female urinary tract infection. Emerg Med Clin North Am 1988;6: 403–17.Google Scholar
  50. 50.
    Neu HC. Microbiologic Aspects of Fluoroquinolones. Am J Ophtalmol 1991;112: 15S–24S.Google Scholar
  51. 51.
    Volaard EJ, Clasener HAL, van Saene HKF, Muller NF. Effect on colonization resistance: an important criterion in selecting antibiotics. DICP 1990;24: 60–6.Google Scholar
  52. 52.
    Diakos GL, Kathpalia SB, Sharifi R, Lolans VT, Jackson GG. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora. Am J of Med 1987;82(Suppl 4A): 290–4.Google Scholar
  53. 53.
    Just PM. Overview of the fluoroquinolone antibiotics. Pharmacotherapy 1993;13(2 Pt 2): 4S–17S.Google Scholar
  54. 54.
    Barriere SL. Therapeutic decisions: assessing clinical fit. Pharmacotherapy 1993;13(2 Pt 2): 18S–22S.Google Scholar
  55. 55.
    Grau S. Dosificaciones especiales de los antibióticos. In: Drobnic L, ed. Temas de actualización del Curso de Formación Continuada. Barcelona: IMAS Hospital del Mar, 1995;1: 79–87.Google Scholar
  56. 56.
    Fang G, Brennen C, Wagener M et al. Use of ciprofloxacin versus use of aminoglycosydes for therapy of complicated urinary tract infections: prospective randomized clinical and pharmacokinetic study. Antimicrob Agts Chemother 1991;35: 1849–55.Google Scholar
  57. 57.
    Foxman Bobbio. Recurrent urinary tract infection: incidence and risk factors. Am J Public Health 1990; 80:331–3.Google Scholar
  58. 58.
    Stamm WE, McKevitt M, Roberts PL, et al. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991;13: 77–84.Google Scholar
  59. 59.
    Stamey TA. Recurrent urinary tract infections in female patients: an overview of management and treatment. Rev Infect Dis 1987;9(suppl 3): 195–210.Google Scholar
  60. 60.
    Stapleton A, Latham RB, Johnson C, Stamm WE. Postcoital Antimicrobial Prophylaxis for recurrent Urinary Tract Infection. JAMA 1990;264: 703–6.Google Scholar
  61. 61.
    Patterson TF, Andriole VT. Bacteriuria in pregnancy. Infect Dis Clin North Am 1987;1: 807–22.Google Scholar
  62. 62.
    Thoumsin H, Aghayan M, Lambotte R. Single dose fosfomy cin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results. Infection 1990;18(Suppl 2): S94–S97.Google Scholar
  63. 63.
    Reeves DS. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: A review. Infection 1992;20(Suppl 4):S313–S320.Google Scholar
  64. 64.
    Zinner S. Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria in pregnancy. Chemotherapy 1990;36(Suppl 1): 50–52.Google Scholar
  65. 65.
    Neu HC. Fosfomycin trometamol: management of lower urinary tract infections. Chemotherapy 1990;36(Suppl 1): 53–5.Google Scholar
  66. 66.
    Briggs GG, Freeman RK, Yaffesj, eds. Drugs in pregnancy and lactation. Baltimore: Williams and Wilkins, 1994.Google Scholar
  67. 67.
    Spach DH, Stapleton AE, Stamm WE. Lack of circumcision increases the risk of urinary tract infection in young men. JAMA 1992;267: 679–81.Google Scholar
  68. 68.
    Malinverni R, Glauser MP. Comparative studies of fluoroqui nolones in the treatment of urinary tract infections. Rev Infect Dis 1988;10(suppl 1): S153–S163.Google Scholar
  69. 69.
    Naber KG. Use of quinolones in urinary tract infections and prostatitis. Rev Infect Dis 1989;11(Suppl 5): S 1321–S1337.Google Scholar
  70. 70.
    Chambers ST. Quinolones. N Z Med J 1995;108: 273–7.Google Scholar
  71. 71.
    Sanders WE Jr. Oral ofloxacin: a critical review of the new drug application. Clin Infect Dis 1992;14: 539–54.Google Scholar
  72. 72.
    Pfau A. Oral ofloxacin: a critical review of the new drug application. Clin Infect Dis 1993;16: 337.Google Scholar
  73. 73.
    Breitenbucher RB. UTI: Managing the most common nursing home infection. Geriatrics 1990;45: 68–75.Google Scholar
  74. 74.
    Zelger GL, Rohner P. Urinary tract infections in geriatric inpatients: Bacteriology data and resistance development. In: Zelger GL, et al. eds. Drug treatment in the elderly. Noordwijk: ESCP, 1994: 149–53.Google Scholar
  75. 75.
    Jaff MR, Paganini EP. Meeting the challenge of geriatric UTIs. Geriatrics 1989;44: 60–6.Google Scholar
  76. 76.
    McCue J. Urinary Tract Infections in the Elderly. Pharmacotherapy 1993;13: 51S–53S.Google Scholar
  77. 77.
    Warren JW, Muncie HL Jr, Bergquist EJ, et al. Sequelae and management of urinary tract infections in the pacient requiring chronic catheterization. J Urol 1981;125: 1–8.Google Scholar
  78. 78.
    Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis and prevention. Am J Med 1991;91(Suppl 3B): 65S–71S.Google Scholar
  79. 79.
    Ansari BM, Jewkes F, Davies SG. Urinary tract infection in children. Epidemiology, natural history, diagnosis and management. J Infect 1995;30: 3–6.Google Scholar
  80. 80.
    Elhanan K, Siplovich, Raz R. Gentamicin once-daily versus thrice-daily in children. J Antimicrob Chemother 1995;35: 327–32.Google Scholar
  81. 81.
    Grimwood K, Abbott MD, Fergusson BA. Single dose gen tamicin treatment of urinary infections in children. N Z Med J 1988;101: 539–41.Google Scholar
  82. 82.
    Kramer SA. Summary of annual meeting of section on Pediatric Urology. Pediatrics 1990;85: 872–8.Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • Santiago Grau
    • 1
  • Josep Monterde
    • 1
  • Ludvik Drobnic
    • 2
  • Margarita Salvadó
    • 3
  1. 1.Pharmacy DepartmentHospital Universitari del MarSpain
  2. 2.Hospital Universitari del MarSpain
  3. 3.Microbiology Laboratory, Laboratori de Referència de CatalunyaSpain

Personalised recommendations